A structured, protocolized approach to analgosedation and neuromuscular blockade improves patient-ventilator synchrony while preventing prolonged ICU stay and acquired weakness.
Key Physiological Equations & Formulas
- Richmond Agitation-Sedation Scale (RASS): $$Score from +4 (combative) to 0 (alert/calm) to -5 (unarousable)$$ Target light sedation (RASS -1 to 0) in most patients, deep sedation (-4 to -5) during neuromuscular blockade.
Practical Clinical Pearls & Bedside Rules
- Analgesia-First (eCAF) Protocol: Control pain first with short-acting opioids (fentanyl, remifentanil) before adding sedatives (propofol, dexmedetomidine).
- Daily Spontaneous Awakening Trial (SAT): Daily interruption of sedative infusions shortens duration of mechanical ventilation by up to 2-3 days.
Initial Settings & Clinical Titration Protocol
| Parameter | Recommended Initial Setting | Titration Goal / Safety Threshold |
|---|---|---|
| Sedation Target | RASS -1 to 0 (Light Sedation) | Facilitates early spontaneous breathing, mobilization, and communication. |
| Neuromuscular Blockade | Cisatracurium 37.5 mg/hr continuous or intermittent boluses | Indicated for early severe ARDS (P/F < 150) with refractory asynchrony for <= 48 hours. |
Bedside Troubleshooting & Red Flags
Warning
Train-of-Four (TOF) Monitoring: Always monitor TOF during paralytic infusions (target 1-2 twitches out of 4) to avoid drug accumulation and persistent post-ICU quadriparesis.
Key Takeaways & Summary
- Always evaluate patient synchrony and physiological response before changing ventilator parameters.
- Maintain lung-protective strategies to minimize driving pressure ($\Delta P$) and mechanical power.
- Continuously reassess liberation and extubation readiness on daily morning rounds.